220 related articles for article (PubMed ID: 22752525)
1. Percutaneous MR-guided cryoablation of prostate cancer: initial experience.
Gangi A; Tsoumakidou G; Abdelli O; Buy X; de Mathelin M; Jacqmin D; Lang H
Eur Radiol; 2012 Aug; 22(8):1829-35. PubMed ID: 22752525
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.
Woodrum DA; Kawashima A; Karnes RJ; Davis BJ; Frank I; Engen DE; Gorny KR; Felmlee JP; Callstrom MR; Mynderse LA
Urology; 2013 Oct; 82(4):870-5. PubMed ID: 23910089
[TBL] [Abstract][Full Text] [Related]
3. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T.
Ahrar K; Ahrar JU; Javadi S; Pan L; Milton DR; Wood CG; Matin SF; Stafford RJ
Invest Radiol; 2013 Jun; 48(6):437-44. PubMed ID: 23511191
[TBL] [Abstract][Full Text] [Related]
4. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up.
Kinsman KA; White ML; Mynderse LA; Kawashima A; Rampton K; Gorny KR; Atwell TD; Felmlee JP; Callstrom MR; Woodrum DA
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):344-349. PubMed ID: 29043385
[TBL] [Abstract][Full Text] [Related]
5. MR imaging-guided focal cryoablation in patients with recurrent prostate cancer.
Bomers JG; Yakar D; Overduin CG; Sedelaar JP; Vergunst H; Barentsz JO; de Lange F; Fütterer JJ
Radiology; 2013 Aug; 268(2):451-60. PubMed ID: 23525206
[TBL] [Abstract][Full Text] [Related]
6. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
7. MR imaging-guided percutaneous cryoablation of the prostate in an animal model: in vivo imaging of cryoablation-induced tissue necrosis with immediate histopathologic correlation.
van den Bosch MA; Josan S; Bouley DM; Chen J; Gill H; Rieke V; Butts-Pauly K; Daniel BL
J Vasc Interv Radiol; 2009 Feb; 20(2):252-8. PubMed ID: 19091600
[TBL] [Abstract][Full Text] [Related]
8. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
[TBL] [Abstract][Full Text] [Related]
9. MR imaging-guided cryoablation of metastatic brain tumours: initial experience in six patients.
Li C; Wu L; Song J; Liu M; Lv Y; Sequeiros RB
Eur Radiol; 2010 Feb; 20(2):404-9. PubMed ID: 19697040
[TBL] [Abstract][Full Text] [Related]
10. T1-weighted MR image contrast around a cryoablation iceball: a phantom study and initial comparison with in vivo findings.
Overduin CG; Bomers JG; Jenniskens SF; Hoes MF; Ten Haken B; de Lange F; Fütterer JJ; Scheenen TW
Med Phys; 2014 Nov; 41(11):112301. PubMed ID: 25370657
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.
Overduin CG; Jenniskens SFM; Sedelaar JPM; Bomers JGR; Fütterer JJ
Eur Radiol; 2017 Nov; 27(11):4828-4836. PubMed ID: 28409355
[TBL] [Abstract][Full Text] [Related]
12. Real-time transrectal ultrasonography-guided hands-free technique for focal cryoablation of the prostate.
de Castro Abreu AL; Bahn D; Chopra S; Leslie S; Matsugasumi T; Gill IS; Ukimura O
BJU Int; 2014 Nov; 114(5):784-9. PubMed ID: 24802231
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous MR Imaging-Guided Cryoablation of Small Renal Masses in a 3-T Closed-Bore MR Imaging Environment: Initial Experience.
van Oostenbrugge TJ; Langenhuijsen JF; Overduin CG; Jenniskens SF; Mulders PFA; Fütterer JJ
J Vasc Interv Radiol; 2017 Aug; 28(8):1098-1107.e1. PubMed ID: 28599873
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous MR-guided whole-gland prostate cancer cryoablation: safety considerations and oncologic results in 30 consecutive patients.
De Marini P; Cazzato RL; Garnon J; Tricard T; Koch G; Tsoumakidou G; Ramamurthy N; Lang H; Gangi A
Br J Radiol; 2019 May; 92(1097):20180965. PubMed ID: 30845821
[TBL] [Abstract][Full Text] [Related]
15. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous MR-guided prostate cancer cryoablation: Predictive factors and oncologic outcomes].
Gaullier M; Tricard T; Garnon J; Cazzato RL; Munier P; De Marini P; Werle P; Lindner V; Gangi A; Lang H
Prog Urol; 2020 Jan; 30(1):12-18. PubMed ID: 31837926
[TBL] [Abstract][Full Text] [Related]
17. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.
Ellis DS; Manny TB; Rewcastle JC
Urology; 2007 Dec; 70(6 Suppl):9-15. PubMed ID: 18194712
[TBL] [Abstract][Full Text] [Related]
18. Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.
Sze C; Tsivian E; Tay KJ; Schulman AA; Davis LG; Gupta RT; Polascik TJ
BMC Urol; 2019 Dec; 19(1):127. PubMed ID: 31805908
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
[TBL] [Abstract][Full Text] [Related]
20. Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas.
Cytron S; Paz A; Kravchick S; Shumalinski D; Moore J
Eur Urol; 2003 Sep; 44(3):315-20; discussion 320-1. PubMed ID: 12932929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
